Pharmaceuticals

Emphysema Treatment Market 2025–2029: Unveiling Growth Developments with the Latest Updates

September 23, 2025 by Marketing Posting

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

#How Is The Emphysema Treatment Market Expected To Grow In Terms Of Size?#_x000D_

The market size for emphysema treatment has been continuously expanding over the recent years. It is predicted to expand from $5.15 billion in 2024 to $5.4 billion in 2025, revealing a compound annual growth rate (CAGR) of 5.0%. The past period’s growth is the result of the widespread smoking problem, evolution in medication, the rise of pulmonary rehabilitation programs, enhancements in diagnosis techniques, along with heightened understanding and knowledge._x000D_

_x000D_

The market for the treatment of emphysema is anticipated to experience robust growth in the coming years. It is predicted to expand to “$7.28 billion in 2029, with a compound annual growth rate (CAGR) of 7.7%. The projected growth during the forecasted period can be ascribed to factors such as the trends of an aging population, tailored treatment strategies, wider accessibility to treatments, emphasis on managing symptoms, and joint health care models. Key trends for the forecasted period comprise gene therapy exploration, educating and empowering patients, the incorporation of artificial intelligence (AI), improved access to treatment, and the advancement of long-lasting medications._x000D_

_x000D_

#Get A Free Sample Of The Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp_x000D_

_x000D_

#What Are The Primary Factors Supporting The Emphysema Treatment Market Expansion?#_x000D_

An increase in the number of Chronic Obstructive Pulmonary Disease (COPD) cases is anticipated to stimulate the expansion of the emphysema treatment market. COPD is a group of disorders that obstruct airflow and cause difficulty in breathing; it includes conditions such as emphysema and chronic bronchitis. In order to inhibit the progression of COPD, employing emphysema treatments is crucial as they target the symptoms, recuperate lung function, and delay disease advancement. For example, in June 2024, the Australian Institute of Health and Welfare (AIHW), reported that in 2022 approximately 638,000 individuals or 2.5% of the Australian population were affected by COPD. In 2023, there was an increase making COPD responsible for 3.6% of the total disease burden, which made up 50% of all burden tied to respiratory conditions. Moreover, in the year 2022, COPD was the underlying factor of 7,691 deaths, equating to 29.6 deaths per 100,000 people, therefore constituting around 4.0% of all casualties in the country. Consequently, the escalating number of Chronic Obstructive Pulmonary Disease (COPD) cases is propelling the emphysema treatment market growth._x000D_

_x000D_

#What Are The Key Segment Trends Observed In The Emphysema Treatment Market?#_x000D_

The emphysema treatment market covered in this report is segmented – _x000D_

_x000D_

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments_x000D_

2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies_x000D_

3) By End-User: Clinics, Surgical Centre, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs_x000D_

2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics_x000D_

3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers_x000D_

4) By Leukotriene Modifiers: Montelukast, Zafirlukast_x000D_

5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems_x000D_

6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines_x000D_

7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides_x000D_

8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation_x000D_

9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care_x000D_

_x000D_

#Which Disruptive Trends Are Driving Change Across The Emphysema Treatment Market?#_x000D_

Major firms in the emphysema market are innovating minimally invasive methods for patients to maintain a competitive market presence. Such procedures involve medical actions or surgical methods that cause minimal disruption to the body’s normal functions. For example, in January 2022, Adena Health System, a healthcare firm based in the US, introduced the Zephyr Valve procedure. This minimally invasive method provides an alternative to the standard lung volume reduction surgery for those suffering from lung hyperinflation, a prevalent problem in emphysema and COPD. Here, the innovative technique involves deploying small, one-direction Zephyr Valves into the lungs’ airways using a bronchoscope. These valves aid in releasing trapped air, halting further accumulation and allowing healthier lung sections to expand, thus enhancing breathing capability._x000D_

_x000D_

#Who Are The Major Stakeholders Operating In The Emphysema Treatment Market?#_x000D_

Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation _x000D_

_x000D_

#Access The Complete Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report_x000D_

_x000D_

#What Regional Factors Are Accelerating Growth In The Emphysema Treatment Market?#_x000D_

North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Customize Your Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10807&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_